Clinical Innovations develops, manufactures and markets state-of-the-art medical devices that improve healthcare outcomes for clinicians and their patients worldwide. With particular emphasis on healthcare solutions for women and their infants, Clinical Innovations has consistently expanded its worldwide presence, becoming the market leader in several product categories, including the Koala® Intrauterine Pressure System and the Kiwi® Vacuum-Assisted Delivery System. With ISO13485 certification and strong relationships with top worldwide medical distributors, Clinical Innovations has the systems and infrastructure in place to promptly respond to market trends and customer suggestions.
Salt Lake City, Sep. 16, 2013- Clinical Innovations, a member of The Pritzker Group’s family of companies and a leading global provider of medical devices with special emphasis on labor and delivery, announces the appointment of Janel Fillinger as its chief financial officer.
Ms. Fillinger joins Clinical Innovations from C.R. Bard, where she most recently served as vice president and controller of Bard Access Systems Division in Salt Lake City.
With 17 years of financial experience in the medical device industry, prior to her most recent role, she held the positoin of vice president and controller of the Bard Japan international division and manager positions at Bard Peripheral Vascular Division. Before her tenure with C.R. Bard, Fillinger was employed as an auditor by Ernst & Young.
“We are very pleased that Janel has joined Clinical Innovations. Janel has the strong operational finance background that we need on our team to help drive the execution of our strategic plan,” said Shacey Petrovic, president and CEO of Clinical Innovations.
Fillinger holds a B.S. in Accounting from Kansas State University, an M.B.A. from the University of Pheonix, and is a Certified Public Accountant.
About Clinical Innovations
About The Pritzker Group’s Middle-Market Investment Team
The Pritzker Group’s middle-market investment team acquires North American-based companies with enterprise values between $100 and $500 million, focusing on quality businesses with leading positions in the manufactured products, healthcare and services sectors. The firm’s proprietary capital base allows for broad flexibility in its investment horizon, transaction structure and approach to creating long-term value, making it an ideal partner for entrepreneur- and family-owned businesses. The Pritzker Group brings large-company credibility, relationships and expertise to the middle market and can support its companies with additional growth capital. The firm’s middle-market and venture capital teams have acquired or invested in more than 100 companies over the past decade. For more information, click here.